Friday, May 27, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



Cuba´s Soberana Plus candidate vaccine to be assessed in Italy

Cuba´s Soberana Plus candidate vaccine to be assessed in Italy

Havana, Jul 25 (Prensa Latina) Cuba's anti-Covid-19 candidate vaccine: Soberana Plus will be assessed in Italy to check its response to SARS-CoV-2 variants, the Finlay Vaccine Institute reported.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

According to official information from the Cuban institution, the serum will be assessed at Amedeo Di Savoia University Clinic. It is the first collaboration between an Italian public scientific institution and Finlay Vaccine Center.

The Italian clinic will assess the ability of the antibodies developed in Cuba to neutralize different variants of SARS-CoV-2.

‘Thanks to friendship and collaboration that emerged when Cuban doctors aided Turin region to fight coronavirus, to the assistance by the Agency for Cultural and Economic Exchange with Cuba, to the Sano Giusto e Solidale Network and to the embassies of both countries, an important collaboration began.’

The only vaccine candidate specially designed to re-stimulate immunity previously induced by other anti-Covid-19 vaccines or by natural infection, Soberana Plus has already completed its phase I and II clinical trials in Cuba.

mh/pll/mem / cdg

name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.